Pharmaceutical Technology Europe-05-01-2008

Pharmaceutical Technology Europe

There are two ways in which 'difficult' samples are usually categorized: either by the problems posed by the physical nature of the post-vivo sample matrix containing the chemical entity to be analysed, or...

Pharmaceutical Technology Europe
Drug Delivery

May 01, 2008

Insulin is one of the world's oldest and most well-known biological drugs, and the need for it is not going to go away as the number of patients diagnosed with diabetes continues to increase. A wealth of clinical evidence shows that good, long-term glucose control in diabetes is key to avoiding complications such as kidney disease, blindness and heart problems.

Pharmaceutical Technology Europe

One of the headlines before going to print was 'Pfizer earnings suffer as patent expiries cause damage'. This US pharma giant has reported a net income decline of 18% for the first quarter, despite the positive impact of the favourable currency rates.

Pharmaceutical Technology Europe
Inside Out

May 01, 2008

The adoption of computers into every aspect of the pharmaceutical industry has been enormous. Some estimates would put productivity and efficiency gains across the pharmaceutical industry at 2–3 times what they were previously. However, they are only just beginning to have an effect in the areas of training and document management, which have traditionally been managed by people and paper systems. With increasingly strict regulations and the growing complexity of processes and training requirements, there are even greater efficiency gains, as well as cost savings, to be achieved by adopting electronic document management systems (eDMS), learning management systems (LMS) and systems for the electronic signing of documents.

Pharmaceutical Technology Europe
Outsourcing review

May 01, 2008

Pharmaceutical Technology Europe

Pharmaceutical Technology Europe
Drug Delivery

May 01, 2008

The adequate absorption and transport of drugs in the body is part of optimal therapy. Drug administration perorally is easy, common and traditional, but occasionally alternative routes are required.

Pharmaceutical Technology Europe
Regulatory Report

May 01, 2008

The assembly of the World Health Organisation (WHO) later this month is expected to feature counterfeit medicines as one of its important discussion points, and there is some hope that the ministers will agree on measures that will strengthen anticounterfeiting legislation and enforcement worldwide.

Pharmaceutical Technology Europe
Manufacturing and processing

May 01, 2008

The pharmaceutical industry must address the release of nonbiodegradable APIs into the environment.

Pharmaceutical Technology Europe

When Pharmaceutical Technology Europe was established 20 years ago, PAT was not a hot topic in the industry. It was started in 2002 by FDA to modernize pharmaceutical manufacturing and increase the efficiency of manufacturing processes.

Pharmaceutical Technology Europe

Practical guidance on how to handle validation failures cannot be found in the existing literature because they are not supposed to happen.